SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-009675
Filing Date
2024-02-02
Accepted
2024-02-02 06:05:12
Documents
2
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244804-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm244804-1_3seq1.xml 3 1592
2 EXHIBIT 24 tm244804d1_ex24.htm EX-24 8852
  Complete submission text file 0001104659-24-009675.txt   11888
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address
Austwick Michael (Reporting) CIK: 0002009903 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38067 | Film No.: 24588701